Comparison of prognostic models in patients with advanced Hodgkin disease: Promising results from integration of the best three systems

Cancer

Volumn 91, Issue 8, 2001, Pages 1467-1478

  Gobbi, Paolo G ^a   Zinzani, Pier Luigi ^a   Broglia, Chiara ^b   Comelli, Mario ^b   Magagnoli, Massimo ^a   Federico, Massimo ^a   Merli, Francesco ^a   Iannitto, Emilio ^c   Tura, Sante ^d   Ascari, Edoardo ^e  

^a UNIVERSITY OF PAVIA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^d Servizio di Ematologia   (Italy)

^e UNIVERSITY OF PALERMO   (Italy)

Author keywords

Hodgkin disease; Modeling; Prognosis; Survival; Time to treatment failure

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER SURVIVAL; CHILD; CONTROLLED STUDY; FEMALE; HODGKIN DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NONBIOLOGICAL MODEL; PRIORITY JOURNAL; PROGNOSIS; STATISTICAL MODEL; TREATMENT FAILURE;

ADOLESCENT; ADULT; AGED; CHILD; FEMALE; HODGKIN DISEASE; HUMANS; MALE; MIDDLE AGED; MODELS, THEORETICAL; PROGNOSIS; SURVIVAL ANALYSIS;

EID: 0035871347     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0142(20010415)91:8<1467::AID-CNCR1154>3.0.CO;2-A     Document Type: Article

References (34)

1. Hodgkin's disease
2. The second chance for advanced Hodgkin's disease
3. Hodgkin's disease prognosis: A directly predictive equation
4. Prognostic factors for survival in Stage III B and IV Hodgkin's disease: A multivariate analysis comparing two specialist treatment centres
5. Prognostic factors among 185 adults with newly diagnosed advanced Hodgkin's disease treated with alternating potentially noncross-resistant chemotherapy and intermediate-dose radiation therapy
6. A numerical prognostic index for clinical use in identification of poor-risk patients with Hodgkin' disease at diagnosis
7. Estimate of expected survival at diagnosis in Hodgkin's disease: A means of weighting prognostic factors and a tool for treatment choice and clinical research. A report from the International Database on Hodgkin's Disease (IDHD)
8. Prognostic factors for disease progression in advanced Hodgkin's disease: An analysis of patients aged under 60 years showing no progression in the first 6 months after starting primary chemotherapy
9. A prognostic score to predict tumor control in advanced Hodgkin's disease
10. Who are the high-risk patients with Hodgkin's disease?
11. Prognosis of patients with advanced Hodgkin's disease. Evaluation of four prognostic models using 344 patients included in the Group d'Etudes des Lymphomes de l'Adulte Study
12. Report of Workshop 5: Early high-dose chemotherapy
13. The International Prognostic Factors Project on advanced Hodgkin's disease: A prognostic index, but no very high risk group
14. Development of effective salvage treatment programs for Hodgkin's disease: An ongoing challenge
15. MOPP/EBV/CAD hybrid chemotherapy with or without limited radiotherapy in advanced or unfavorably presenting Hodgkin's disease: A report from the Italian Lymphoma Study Group
16. Long-term results from MOPPEBVCAD chemotherapy with optional limited radiotherapy in advanced Hodgkin's disease
17. Hodgkin's disease: Summary of twenty years' experience
18. Efficacia terapeutica della polichemioterapia CcVPP nel morbo di Hodgkin
19. Re-evaluation of prognostic significance of symptoms in Hodgkin's disease
20. Treatment of intermediate stages
21. The management of Stage I-II Hodgkin's disease with irradiation alone or combined modality therapy: The Stanford experience
22. Treatment of advanced-stage massive mediastinal Hodgkin's disease: The case for combined modality treatment
23. Treatment of relapsed Hodgkin's disease
24. Report of the committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds Meeting
25. Should poor risk patients with Hodgkin's disease be sorted out for intensive treatments?
26. Conventional-dose salvage combination chemotherapy in patients relapsing with Hodgkin's disease after combination chemotherapy: The low probability for cure
27. Reporting outcomes in Hodgkin's disease and lymphoma
28. Nonparametric estimation from incomplete observations
29. Regression model and life-tables
30. A dose and time response analysis of the treatment of Hodgkin's disease with MOPP chemotherapy
31. Twelve years experience with high-dose therapy and autologous stem cell transplantation for high-risk Hodgkin's disease patients in first remission after MOPP/ABVD chemotherapy
32. Evolution of the concept of prognostication in therapy of Hodgkin's lymphoma
33. Verification and comparison of two different predictive equations in Hodgkin's disease